Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $22,772 | 21 | 81.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,475 | 3 | 16.1% |
| Food and Beverage | $599.04 | 7 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Co., Ltd. | $27,472 | 28 | $0 (2019) |
| Indivior Inc. | $125.00 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $124.69 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $124.99 | 1 | E.R. Squibb & Sons, L.L.C. ($124.99) |
| 2019 | $14,410 | 20 | Otsuka Pharmaceutical Co., Ltd. ($14,410) |
| 2018 | $13,187 | 9 | Otsuka Pharmaceutical Co., Ltd. ($13,062) |
| 2017 | $124.69 | 1 | Otsuka America Pharmaceutical, Inc. ($124.69) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/27/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,192.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/08/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $52.22 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $3,426.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $3,426.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $367.08 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $357.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $62.90 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $48.44 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $19.52 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $12.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $12.16 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $341.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $88.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $45.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $24.04 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $18.14 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $341.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | In-kind items and services | $37.27 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2019 | Otsuka Pharmaceutical Co., Ltd. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $3,426.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/21/2018 | Otsuka Pharmaceutical Co., Ltd. | ABILIFY MAINTENA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,157.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2018 | Otsuka Pharmaceutical Co., Ltd. | ABILIFY MAINTENA (Drug) | Travel and Lodging | In-kind items and services | $354.66 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2018 | Otsuka Pharmaceutical Co., Ltd. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2018 | Otsuka Pharmaceutical Co., Ltd. | ABILIFY MAINTENA (Drug) | Travel and Lodging | In-kind items and services | $355.54 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 83 | 314 | $113,295 | $30,889 |
| 2022 | 4 | 100 | 293 | $108,424 | $27,991 |
| 2021 | 8 | 221 | 737 | $243,781 | $69,099 |
| 2020 | 5 | 112 | 370 | $122,167 | $36,093 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 215 | $80,237 | $22,848 | 28.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 14 | 57 | $9,302 | $3,108 | 33.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $10,293 | $2,188 | 21.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 13 | 13 | $6,825 | $1,511 | 22.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 12 | $6,638 | $1,235 | 18.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 208 | $75,664 | $18,709 | 24.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 40 | 40 | $20,616 | $5,726 | 27.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 16 | 33 | $5,286 | $1,840 | 34.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $6,858 | $1,716 | 25.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 53 | 461 | $154,059 | $43,127 | 28.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 44 | 44 | $20,988 | $6,591 | 31.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 33 | 35 | $18,900 | $5,571 | 29.5% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Facility | 2021 | 28 | 84 | $12,348 | $4,723 | 38.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 18 | 52 | $15,340 | $4,693 | 30.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 31 | $8,277 | $2,032 | 24.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 13 | 13 | $6,474 | $1,219 | 18.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 17 | 17 | $7,395 | $1,143 | 15.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 42 | 277 | $87,335 | $26,112 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 29 | 31 | $15,990 | $5,447 | 34.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 15 | 18 | $8,550 | $1,800 | 21.1% |
| 90833 | Psychotherapy, 30 minutes | Facility | 2020 | 11 | 29 | $4,067 | $1,708 | 42.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 15 | 15 | $6,225 | $1,027 | 16.5% |
About Dr. Evan Garner, MD
Dr. Evan Garner, MD is a Psychiatry healthcare provider based in Mountain View, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386674869.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evan Garner, MD has received a total of $27,847 in payments from pharmaceutical and medical device companies, with $124.99 received in 2024. These payments were reported across 31 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($22,772).
As a Medicare-enrolled provider, Garner has provided services to 516 Medicare beneficiaries, totaling 1,714 services with total Medicare billing of $164,073. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Mountain View, CA
- Active Since 07/03/2006
- Last Updated 06/21/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386674869
Products in Payments
- REXULTI (Drug) $14,535
- ABILIFY MAINTENA (Drug) $13,062
- SUBOXONE SUBLINGUAL FILM (Drug) $125.00
- COBENFY (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Mountain View
Zahida Tayyib, M.d, M.D
Psychiatry — Payments: $8,415
Dr. Mark Smolenski, M.d, M.D
Psychiatry — Payments: $5,178
Dr. Yang Xu, M.d, M.D
Psychiatry — Payments: $1,437
Katherine Taylor, Md, MD
Psychiatry — Payments: $1,401
Dr. Thomas Havel, M.d, M.D
Psychiatry — Payments: $805.49
Vanita Chawla, M,D., M.p.h, M,D., M.P.H
Psychiatry — Payments: $667.98